These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22279939)

  • 1. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
    Subramanian S; John M
    Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
    Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
    Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activity of receptor guanylyl cyclases in tissues of rats with neonatal streptozotocin diabetus mellitus and the influence of intranasal administration of insulin and serotonin].
    Shpakov AO; Chistiakova OV; Derkach KV; Moĭseiuk IV; Bondareva VM
    Tsitologiia; 2011; 53(7):591-9. PubMed ID: 21938932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal insulin treatment improves memory and learning in a rat amyloid-beta model of Alzheimer's disease.
    Farzampour S; Majdi A; Sadigh-Eteghad S
    Physiol Int; 2016 Sep; 103(3):344-353. PubMed ID: 28229638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
    Weiner HL; Lemere CA; Maron R; Spooner ET; Grenfell TJ; Mori C; Issazadeh S; Hancock WW; Selkoe DJ
    Ann Neurol; 2000 Oct; 48(4):567-79. PubMed ID: 11026440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin.
    Lu F; Li X; Suo AQ; Zhang JW
    Chin Med J (Engl); 2010 Jul; 123(14):1864-70. PubMed ID: 20819569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains.
    Zhang T; Pan BS; Zhao B; Zhang LM; Huang YL; Sun FY
    Neuroscience; 2009 Jul; 161(4):1045-56. PubMed ID: 19376202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
    Baraka A; ElGhotny S
    Eur J Pharmacol; 2010 Sep; 641(2-3):123-7. PubMed ID: 20639139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
    Xia CQ; Wang J; Shen WC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.
    Salkovic-Petrisic M; Tribl F; Schmidt M; Hoyer S; Riederer P
    J Neurochem; 2006 Feb; 96(4):1005-15. PubMed ID: 16412093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
    Bak AM; Egefjord L; Gejl M; Steffensen C; Stecher CW; Smidt K; Brock B; Rungby J
    Expert Opin Ther Targets; 2011 Oct; 15(10):1153-62. PubMed ID: 21749267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease.
    Vandal M; White PJ; Tremblay C; St-Amour I; Chevrier G; Emond V; Lefrançois D; Virgili J; Planel E; Giguere Y; Marette A; Calon F
    Diabetes; 2014 Dec; 63(12):4291-301. PubMed ID: 25008180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.